Medicare Act Increases Risk of Declaratory Judgment Actions Against Innovators

Although not widely publicized, several provisions of the Medicare Prescription Drug, Modernization, and Improvement Act (the Medicare Act) may prove important to innovator pharmaceutical companies.


Download PDF Share Back To Listing
Loading data